vs

Side-by-side financial comparison of NU SKIN ENTERPRISES, INC. (NUS) and UiPath, Inc. (PATH). Click either name above to swap in a different company.

UiPath, Inc. is the larger business by last-quarter revenue ($411.1M vs $370.3M, roughly 1.1× NU SKIN ENTERPRISES, INC.). UiPath, Inc. runs the higher net margin — 48.4% vs 3.9%, a 44.5% gap on every dollar of revenue. On growth, UiPath, Inc. posted the faster year-over-year revenue change (15.9% vs -16.9%). UiPath, Inc. produced more free cash flow last quarter ($25.1M vs $5.9M). Over the past eight quarters, UiPath, Inc.'s revenue compounded faster (0.7% CAGR vs -5.8%).

Nu Skin Enterprises, Inc. is an American multilevel marketing company that develops and sells personal care products and dietary and nutritional supplements. Under the Nu Skin and Pharmanex brands, the company sells its products in 54 markets through a network of approximately 1.2 million independent distributors.

UiPath Inc. is a global software company that develops artificial intelligence (AI) and agentic automation and orchestration software. The company's software enables the building and orchestration of AI agents to automate complex processes and workflows.

NUS vs PATH — Head-to-Head

Bigger by revenue
PATH
PATH
1.1× larger
PATH
$411.1M
$370.3M
NUS
Growing faster (revenue YoY)
PATH
PATH
+32.8% gap
PATH
15.9%
-16.9%
NUS
Higher net margin
PATH
PATH
44.5% more per $
PATH
48.4%
3.9%
NUS
More free cash flow
PATH
PATH
$19.2M more FCF
PATH
$25.1M
$5.9M
NUS
Faster 2-yr revenue CAGR
PATH
PATH
Annualised
PATH
0.7%
-5.8%
NUS

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
NUS
NUS
PATH
PATH
Revenue
$370.3M
$411.1M
Net Profit
$14.5M
$198.8M
Gross Margin
70.7%
83.3%
Operating Margin
6.3%
3.2%
Net Margin
3.9%
48.4%
Revenue YoY
-16.9%
15.9%
Net Profit YoY
140.1%
1966.2%
EPS (diluted)
$0.27
$0.37

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NUS
NUS
PATH
PATH
Q4 25
$370.3M
$411.1M
Q3 25
$364.2M
$361.7M
Q2 25
$386.1M
$356.6M
Q1 25
$364.5M
$423.6M
Q4 24
$445.6M
$354.7M
Q3 24
$430.1M
$316.3M
Q2 24
$439.1M
$335.1M
Q1 24
$417.3M
$405.3M
Net Profit
NUS
NUS
PATH
PATH
Q4 25
$14.5M
$198.8M
Q3 25
$17.1M
$1.6M
Q2 25
$21.1M
$-22.6M
Q1 25
$107.5M
$51.8M
Q4 24
$-36.1M
$-10.7M
Q3 24
$8.3M
$-86.1M
Q2 24
$-118.3M
$-28.7M
Q1 24
$-533.0K
$33.9M
Gross Margin
NUS
NUS
PATH
PATH
Q4 25
70.7%
83.3%
Q3 25
70.5%
82.2%
Q2 25
68.8%
82.1%
Q1 25
67.8%
84.8%
Q4 24
62.7%
82.0%
Q3 24
70.1%
80.0%
Q2 24
70.0%
83.5%
Q1 24
70.5%
86.8%
Operating Margin
NUS
NUS
PATH
PATH
Q4 25
6.3%
3.2%
Q3 25
5.9%
-5.6%
Q2 25
8.0%
-4.6%
Q1 25
-2.7%
7.9%
Q4 24
-11.9%
-12.2%
Q3 24
4.2%
-32.7%
Q2 24
-28.6%
-14.8%
Q1 24
2.1%
3.7%
Net Margin
NUS
NUS
PATH
PATH
Q4 25
3.9%
48.4%
Q3 25
4.7%
0.4%
Q2 25
5.5%
-6.3%
Q1 25
29.5%
12.2%
Q4 24
-8.1%
-3.0%
Q3 24
1.9%
-27.2%
Q2 24
-26.9%
-8.6%
Q1 24
-0.1%
8.4%
EPS (diluted)
NUS
NUS
PATH
PATH
Q4 25
$0.27
$0.37
Q3 25
$0.34
$0.00
Q2 25
$0.43
$-0.04
Q1 25
$2.14
$0.09
Q4 24
$-0.73
$-0.02
Q3 24
$0.17
$-0.15
Q2 24
$-2.38
$-0.05
Q1 24
$-0.01
$0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NUS
NUS
PATH
PATH
Cash + ST InvestmentsLiquidity on hand
$239.8M
$1.4B
Total DebtLower is stronger
Stockholders' EquityBook value
$805.2M
$1.9B
Total Assets
$1.4B
$2.9B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NUS
NUS
PATH
PATH
Q4 25
$239.8M
$1.4B
Q3 25
$253.0M
$1.4B
Q2 25
$265.4M
$1.6B
Q1 25
$213.6M
$1.6B
Q4 24
$198.0M
$1.6B
Q3 24
$237.8M
$1.7B
Q2 24
$232.9M
$1.9B
Q1 24
$221.2M
$1.9B
Stockholders' Equity
NUS
NUS
PATH
PATH
Q4 25
$805.2M
$1.9B
Q3 25
$799.8M
$1.7B
Q2 25
$787.8M
$1.7B
Q1 25
$754.0M
$1.8B
Q4 24
$651.5M
$1.7B
Q3 24
$706.9M
$1.8B
Q2 24
$686.2M
$2.0B
Q1 24
$810.2M
$2.0B
Total Assets
NUS
NUS
PATH
PATH
Q4 25
$1.4B
$2.9B
Q3 25
$1.4B
$2.6B
Q2 25
$1.4B
$2.6B
Q1 25
$1.4B
$2.9B
Q4 24
$1.5B
$2.7B
Q3 24
$1.6B
$2.7B
Q2 24
$1.6B
$2.8B
Q1 24
$1.7B
$3.0B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NUS
NUS
PATH
PATH
Operating Cash FlowLast quarter
$16.6M
$28.3M
Free Cash FlowOCF − Capex
$5.9M
$25.1M
FCF MarginFCF / Revenue
1.6%
6.1%
Capex IntensityCapex / Revenue
2.9%
0.8%
Cash ConversionOCF / Net Profit
1.15×
0.14×
TTM Free Cash FlowTrailing 4 quarters
$46.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NUS
NUS
PATH
PATH
Q4 25
$16.6M
$28.3M
Q3 25
$27.5M
$41.6M
Q2 25
$35.8M
$119.0M
Q1 25
$389.0K
$146.1M
Q4 24
$25.8M
$28.1M
Q3 24
$31.4M
$46.4M
Q2 24
$51.2M
$100.0M
Q1 24
$3.3M
$145.6M
Free Cash Flow
NUS
NUS
PATH
PATH
Q4 25
$5.9M
$25.1M
Q3 25
$17.6M
Q2 25
$35.8M
$106.2M
Q1 25
$-13.2M
$138.7M
Q4 24
$13.2M
$23.2M
Q3 24
$22.8M
$45.0M
Q2 24
$43.1M
$98.8M
Q1 24
$-9.0M
$141.8M
FCF Margin
NUS
NUS
PATH
PATH
Q4 25
1.6%
6.1%
Q3 25
4.8%
Q2 25
9.3%
29.8%
Q1 25
-3.6%
32.7%
Q4 24
3.0%
6.5%
Q3 24
5.3%
14.2%
Q2 24
9.8%
29.5%
Q1 24
-2.1%
35.0%
Capex Intensity
NUS
NUS
PATH
PATH
Q4 25
2.9%
0.8%
Q3 25
2.7%
0.0%
Q2 25
0.0%
3.6%
Q1 25
3.7%
1.7%
Q4 24
2.8%
1.4%
Q3 24
2.0%
0.4%
Q2 24
1.9%
0.4%
Q1 24
2.9%
0.9%
Cash Conversion
NUS
NUS
PATH
PATH
Q4 25
1.15×
0.14×
Q3 25
1.61×
26.25×
Q2 25
1.69×
Q1 25
0.00×
2.82×
Q4 24
Q3 24
3.79×
Q2 24
Q1 24
4.29×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

NUS
NUS

Other$161.9M44%
Mainland China Segment$52.0M14%
Southeast Asia Pacific Segment$50.5M14%
Europe And Africa Segment$41.8M11%
Hong Kong Taiwan Segment$29.6M8%
South Korea Segment$28.4M8%
Rhyz Other Segment$6.1M2%

PATH
PATH

Subscription Services$247.6M60%
License$150.0M36%
Professional Services And Other$13.5M3%

Related Comparisons